Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 42NIH 6NETWORK 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 3Bronchiolitis Obliterans Syndrome 1

Interventions

Cytarabine 52Methotrexate 33Cyclophosphamide 33Daunorubicin 29Gene Expression Profiling 27Flow Cytometry 23Vincristine 22Mercaptopurine 19Dexamethasone 19Asparaginase 19Filgrastim 18Microarray Analysis 16Etoposide 16Radiotherapy 15Thioguanine 14Prednisone 14Leucovorin 14Idarubicin 13Polymerase Chain Reaction 12Peripheral Blood Stem Cell Transplantation 12Gemtuzumab 12Doxorubicin 12pegaspargase 10Hydrocortisone 10Calcium Dobesilate 10Busulfan 10Reverse Transcriptase Polymerase Chain Reaction 9Mitoxantrone 9Granulocyte Colony-Stimulating Factor 9Cytogenetic Analysis 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Leukemia × Alemtuzumab × Clear all
NCT00074282 2023-06-29

Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL

Eastern Cooperative Oncology Group

Phase 2 Completed
102 enrolled 11 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00006390 2023-06-22

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Eastern Cooperative Oncology Group

Phase 2 Completed
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00800943 2008-12-03

CRC005

Chronic Lymphocytic Leukemia Research Consortium

Phase 2 Unknown
31 enrolled
LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡